Xtant Medical Holdings, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $133.9M | $117.3M | $91.3M | $58.0M | $55.3M |
| Gross profit | $84.3M | $68.2M | $55.5M | $32.1M | $32.5M |
| Operating income | $7.3M | -$12.1M | -$10.2M | -$6.8M | -$3.9M |
| Operating expenses | $77.0M | $80.3M | $65.6M | $38.9M | $36.3M |
| Cost of revenue | $49.7M | $49.1M | $35.8M | $25.8M | $22.8M |
| Cash from operations | $12.5M | -$11.9M | -$9.5M | -$5.3M | $439,000 |
| Capital expenditure | $2.4M | $4.1M | $1.5M | $1.8M | $2.1M |
| Free cash flow | $10.2M | -$16.0M | -$11.0M | -$7.1M | -$1.7M |
| Total assets | $94.1M | $93.8M | $92.6M | $60.2M | $54.7M |
| Total liabilities | $43.2M | $50.9M | $41.3M | $26.1M | $23.8M |
Shares outstanding 140.3M · Free float 20.9%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.